## ## ## ## ## ## ## ## ## |CONTENTS|PAGE| |---|---| |Chair'sstatement|1| |Trustees'report|2-14| |Auditors'report|15-18| |Statementoffinancialactivities|19| |Balancesheet|20| |Notestothefinancialstatements|21-30| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |ChapterRegion|Location|Date|Hospitals|Delegates|Faculty|Totalnumber|Totalnumber|Surgeons|Oncologists|Radiologists|Pathologists|Nurses|Othe| |---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||||ofClinicians||||||| |2024|||||||||||||| |Wessex|Basingstoke|24-Jan|7|38|10|r|48|25|3|6|4|10|0| |SouthWales|Cardiff|11-Mar|9|39|14|r|53|25|9|5|3|10|1| |London1|London|02-May|26|133|13|iv|146|60|19|20|10|33|4| |NorthWales|Conwy|19-Jul|3|30|11|,|41|18|2|4|1|15|1| |Scotland1|Edinburgh|11-Sep|17|45|17|r|62|33|14|4|3|8|0| |Oxford|Thame|07-Nov|4|37|11||48|28|5|6|0|8|1| |2025|||||||||||||| |Trent|Nottingham|30-Jan|4|37|14|r|51|24|6|7|2|8|4| |Yorkshire
Total|York|13-Mar|16
88|82
441|12
402|.|94
**8**43|47
280|15
73|12
64,|5
28|12
104|3
14| |Year|ChapterRegion|Date|Location| |---|---|---|---| |9|London2|8thMay2025|CentralLondon| |10|RepublicofIreland|2ndSeptember2025|Dublin| |11|NorthernIreland|4thSeptember2025|Belfast| |12|Scotland2|8th October2025|Glasgow| |13|Southwest|6th November2025|Bristol| |14|WestMidlands|21stJanuary2026|Edgbaston| |15|Northwest|10-14thMarch2026|Manchester| |16|Northern|May2026|Newcastle| |17|EastAnglia|July2026|Cambridge/Norwich| |18|London3|September2026|London| |19|Mersey|November2026|Liverpool| |20|Washup|December|Basingstoke| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Trustees|| |---|---| |MrSArnold|ColorectalSurgeon| |MrTDeWinter|DirectorNHS/PrivateHealthcareSector| |MrsMEdwards|RetiredNHSChiefExecutive| |MrHGardener|Solicitor/Judge| |MrPHousden|NHS/PrivateHealthcareConsultant| |MrCMcCormack|RetiredBankCEO| |MrFMohamed|ColorectalSurgeon| |ProfessorBMoran|ColorectalSurgeon| |MrMReesOBE|HepatobiliarySurgeon| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||Restricted|Unrestricted|Total|Total| |---|---|---|---|---|---| |||Funds|Funds|Funds|Funds| ||Notes|2025|2025|2025|2024| |||£|£|£|£| |IncomingResources|||||| |Incomingresourcesfromvoluntarysources:|||||| |Donationsfromthepublic|2||54,411|54,411|38,036| |Trustincome|2|90,000|3,981|93,981|206,500| |Legacyincome|2||182,909|182,909|| |Fundraisingincome|2||57,725|57,725|33,494| |Incomeresourcesfromcharitableactivities:|||||| |Courses|2||4,877|4,877|15,794| |Governmentgrants|2||||| |Otherincome:|||||| |Investmentincome|2||20,842|20,842|17,060| |Totalincomingresources||90,000|324,745|414,745|310,884| |Resourcesexpended|||||| |Costofgeneratingfunds|3|-|73,720|73,720|98,112| |Charitableactivities:|||||| |Researchexpenditure|3||45,124|45,124|8,725| |Coursecosts|3|102,925|144,506|247,431|144,152| |TotalResourcesexpended||102,925|263,350|366,275|250,989| |Netincomingresourcesforthe|year|(12,925)|61,395|48,470|59,895| |Unrealisedgains/(losses)on|||||| |revaluationofinvestments||-|(9,698)|(9,698)|| |Netmovementoffunds||(12,925)|51,697|38,772|59,895| |At31March2024||107,400|757,671|865,071|805,176| |At31March2025||94,475|809,368|903,843|865,071| ## |||BALANCESHEET|||| |---|---|---|---|---|---| ||FORTHEYEARENDED31MARCH2025||||| |||2023||2024|| ||Notes||||| |Fixedassets|||||| |Tangibleassets|7|2,408|||4,288| |Investments|8|394,950|||87,316| |Currentassets|||||| |Accountsreceivable||12,537|13,253||| |Prepaymentsandotherdebtors||4,094|22,547||| |Cashatbankaridinhand||557,414|768,730||| |||574,045|805,530||| |Creditors:amountsfallingduewithintheyear|||||| |Accountspayable||10,001|20,984||| |Employmentcreditors||4,167|4,139||| |Accruals||42,392|5,940||| |Grantspledged|9|11,000|||| |Deferredincome|||||| |||67,560|.063||| |Netcurrentassets||512,560|||771,467| |Totalassetslesscurrentliabilities||903,843|||865,071| |runcts|||||| |Restricted|10|94,475|||107,400| |Designated|11|550,000|||550.000| |General|11|259,368|||207,671| |||903,843|||865,071| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||Total|Total| |---|---|---|---|---|---|---| ||Restrictedfunds||Unrestrictedfunds||funds|funds| ||2025|2024|2025|2024|2025|2024| ||£|£|£|£|£|£| |Incomingresourcesfrom|voluntarysources|||||| |Donationsfromthe||||||| |public||-|54,411|38,036|54,411|38,036| |TrustIncome|90,000|189,000|3,981|17,500|93,981|206,500| |LegacyIncome|||182,909|-|182,909|| |FundraisingIncome|-|-|57,725|33,494|57,725|33,494| |Incomingresourcesfrom|charitableactivities|||||| |Courses|-||4,877|15,794|4,877|15,794| |OtherIncome||||||| |InvestmentIncome|-|-|20,842|17,060|20,842|17,060| |RefundreR&Drepaid|-|-||||| |Totalcosts|90,000|189,000|324,745|121,884|414,745|310,884| ## ## ||Costsof|||Total|Total| |---|---|---|---|---|---| ||generating|Research|Course|funds|funds| ||funds|expenditure|costs|2025|2024| ||£|£|£|£|£| |Trainingcourses|-||143,652|143,652|54,387| |Researchexpenditure(note9)|-|29,226||29,226|| |Wagesandsalaries(note4)|52,082|11,690|76,313|140,085|129,052| |Facilitiescosts||-|-|-|-| |Consultancyandprofessionalfees|12,348|2,771|18,094|33,213|44,363| |Fundraisingcosts|2,897|||2,897|2,230| |Supportcosts|6,393|1,437|9,372|17,202|20,417| |Totalcosts|73,720|45,124|247,431|366,275|250,989| ## ## ## ## ## |RESOURCESEXPENDED(continued...)||| |---|---|---| ||2025|2024| ||£|£| |Analysisofsupportcosts||| |Depreciation|1,880|2,464| |ITcosts|7,118|7,498| |Auditfees|5,940|5,940| |Bankfees|259|355| |Otherofficeadministrativesupportcosts|2,005|4,160| ||17,202|20,417| ## |STAFFCOSTSANDTRUSTEES'REMUNERATION||| |---|---|---| ||2025|2024| ||f|£| |Staffcostsandtrustee'sremuneration||| |Wagesandsalaries|119,373|113,689| |Socialsecurity|7,708|2,978| |Pensioncosts|13,004|12,385| ||140,085|129,052| ## ||Theaveragenumberofemployeesduringtheyearwasmadeup|asfollows:|| |---|---|---|---| |||2025|2024| |||No.|No.| ||Total|3|3| |6.|NETINCOMINGRESOURCESFORTHEYEAR||| ||Thisisstatedaftercharging:|2025|2024| |||£|£| ||Auditorsremuneration—asauditor|5,940|5,940| ||Depreciation|1,880|2,464| ## ## ## ## ## |||Computers|Equipment|Total| |---|---|---|---|---| |||f|£|£| ||Cost|||| ||At1April2024|95,667|27,426|123,093| ||Additions|||| ||At31March2025|95,667|27,426|123,093| ||Depreciation|||| ||At1April2024|91,844|26,961|118,805| ||Depreciationcharge|1,764|116|1,880| ||At31March2025|93,608|27,077|120,685| ||Netbookvalue|||| ||At31March2024|3,823|465|4,288| ||At31March2025|2,059|349|2,408| |8.|INVESTMENTS|||| ||||2025|2024| ||||£|£| ||Marketvalue|||| ||At1stApril2024||87,316|739,150| ||Investmentincomereceivedreinvested||2,332|2,316| ||Additions/(withdrawals)||315,000|(654,150)| ||Gain/(Loss)onfairvaluemovements||(9,698)|| ||At31March2025||394,950|87,316| ||Investmentsheldasfollows:|||| ||Globalinvestmentunitfunds||382,665|| ||Cashheldbyinvestmentmanagers||12,285|87,316| ||At31March2025||394,950|87,316| ## ## ## ## |ANALYSISOFGRANTS||| |---|---|---| ||2025|2024| ||f|f| |Researchexpenditureduringtheyear||| |Grantsissuedbythecharityduringtheyear|11,000|| |GrantspayablechargedtotheSoFAduringtheyear|11,000|| ||2025|2024| ||£|£| |Grantspayable||| |Grantspayableat31stMarch2024||| |GrantspayablechargedtotheSoFAduringtheyear|11,000|| |Grantspaidduringtheyear||| |Grantreceiptsreceivedduringtheyear||| |Grantspayableat31stMarch2025|11,000|| |Inadditiontotheabove,thetrusteeshadalsoapprovedthefollowinggrantstobe madeat31March2025,||| |butwhicharenotaccruedforwithinthesefinancialstatements,asthecharitystillhadcontrolofthesefunds||| |at31March2025:||| ||2025|2024| ||£|£| |Grantsapproved||| |None||| |Grantspledgescommitted,butnotaccruedat31stMarch2025||| ## ## ## ## |RESTRICTEDFUNDS|||||| |---|---|---|---|---|---| ||At||||At| ||1April|Incoming|Outgoing||31March| ||2024|resources|resources|Transfers|2025| ||£|£|£|£|£| |Restrictedfunds|||||| |OReCO|105,400|90,000|(102,925)||92,475| |Equipment-MDTProjector|2,000|||-|2,000| |TotalRestrictedfunds-2025|107,400|90,000|(102,925)||94,475| ## ||At||||At| |---|---|---|---|---|---| ||1April|Incoming|Outgoing||31March| ||2023|resources|resources|Transfers|2024| ||£|£|£|£|£| |Restrictedfunds|||||| |OReCO||185,000|(79,600)|-|105,400| |TraintheTrainers||4,000|(4,000)|-|| |ColorectalSymposium|8,426|-|(8,426)|-|| |Equipment—MDTprojector|2,000|-|-|-|2,000| |TotalRestrictedfunds-2024|10,426|189,000|(92,026)|-|107,400| ## ## ## ## ## ## ||At||||At| |---|---|---|---|---|---| ||1April|Incoming|Outgoing||31March| ||2024|resources|resources|Transfers|2025| ||£|£|£|£|£| |Designatedfunds|||||| |Contingencyreserve|300,000||||300,000| |Research&Educationcommitments|200,000||||200,000| |Fixedassetfund|50,000||||50,000| |TotalDesignatedfunds-2025|550,000||||550,000| |Generalfunds|207,671|324,745|(273,048)||259,368| |TotalUnrestrictedfunds-2025|757,671|324,745|(273,048)||809,368| ||At||||At| |---|---|---|---|---|---| ||1April|Incoming|Outgoing||31March| ||2023|resources|resources|Transfers|2024| ||£|£|£|£|£| |Designatedfunds|||||| |Contingencyreserve|300,000||||300,000| |Research&Educationcommitments|200,000||-||200,000| |Fixedassetfund|50,000||-||50,000| |TotalDesignatedfunds—2024|550,000|-|-||550,000| |Generalfunds|244,750|121,884|(158,963)||207,671| |TotalUnrestrictedfunds-2024|794,750|121,884|(158,963)||757,671| ## ## ## ||Unrestrictedfunds|Unrestrictedfunds||| |---|---|---|---|---| ||Designated|GeneralFunds|Restricted|Total| ||Funds||Funds|| ||£|£|£|£| |Fixedassetinvestments|394,950|-|-|394,950| |Tangiblefixedassets||2,408||2,408| |Cashatbankandinhand|155,050|307,889|94,475|557,414| |Othernetassets/(liabilities)||(50,929)||(50,929)| ||550,000|259,368|94,475|903,843| ## ## ##